Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07230145
PHASE1

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd

View on ClinicalTrials.gov

Summary

This is a clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic and immunogenicity of single subcutaneous injection of SHR-4658 in healthy volunteers and volunteers with elevated blood pressure.

Official title: A Double-Blind, Randomized, Dose-Escalating Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-11

Completion Date

2026-07

Last Updated

2025-11-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

SHR-4658 Injection.

SHR-4658 injection.

DRUG

SHR-4658 Placebo Injection

SHR-4658 placebo injection.

Locations (1)

Beijing Anzhen Hospital Capital Medical University

Beijing, Beijing Municipality, China